Trailing-twelve-month (TTM) revenue is $107.36 Million with a year-over-year growth of (4.97%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $29,161,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $26,635,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-15 |
| Q1 FY2026Period ended 2026-03-31 | $24,917,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $26,650,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $107,363,000 |
Current P/S: $15,032,129 market capitalization ÷ $107,363,000 TTM revenue = 0.14x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $26.65M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:07:48.452Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| Consolidated other, including freight | $800,000 | $1M | $800,000 | $800,000 | $1M | $2M |
| Consolidated pack sales | $2M | $4M | $8M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $96M | $92M | $98M | $84M | $79M | $69M |
| EMEA | $14M | $14M | $15M | $12M |
$107.36M
$107.36 Million
(4.97%)
vs. $112.98M a year ago (TTM)
(7.43%)
5 Year compound annual growth rate
1 Year
(4.97%)
3 Year
(7.70%)
5 Year
(7.43%)
10 Year
(4.97%)
15 Year
(4.44%)
20 Year
(6.43%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $108.04M | ($9.83M) | (8.34%) |
| 2024 | $117.87M | ($14.09M) | (10.68%) |
| 2023 | $131.96M | ($5.25M) | (3.83%) |
| 2022 | $137.21M | ($22.55M) | (14.12%) |
| 2021 | $159.76M | +$8.36M | +5.52% |
| 2020 |
TTM Growth
(4.97%)
3-Year CAGR
(7.70%)
5-Year CAGR
(7.43%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:07:48.452Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $6M |
| $4M |
| Consolidated product sales | $155M | $146M | $151M | $130M | $125M | $112M |
|---|
| $9M |
| North America | $48M | $45M | $47M | $42M | $43M | $40M |
|---|
| $151.41M |
| ($6.32M) |
| (4.01%) |
| 2019 | $157.73M | ($15.83M) | (9.12%) |
| 2018 | $173.56M | ($3.14M) | (1.78%) |
| 2017 | $176.70M | ($3.61M) | (2.00%) |
| 2016 | $180.30M | +$37,000 | +0.02% |
